The Joint Corp Net Income
| JYNT Stock | USD 9.72 0.13 1.36% |
As of the 6th of February, Joint Corp retains the Risk Adjusted Performance of 0.1488, downside deviation of 1.97, and Market Risk Adjusted Performance of 0.379. Joint Corp technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from Joint Corp's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Joint Corp's valuation are summarized below:The Joint Corp does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Is there potential for Health Care Providers & Services market expansion? Will Joint introduce new products? Factors like these will boost the valuation of Joint Corp. Expected growth trajectory for Joint significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Joint Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Joint Corp requires distinguishing between market price and book value, where the latter reflects Joint's accounting equity. The concept of intrinsic value - what Joint Corp's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Joint Corp's price substantially above or below its fundamental value.
Understanding that Joint Corp's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Joint Corp represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Joint Corp's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Joint Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Joint Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Joint Corp.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Joint Corp on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding The Joint Corp or generate 0.0% return on investment in Joint Corp over 90 days. Joint Corp is related to or competes with Biote Corp, CareCloud, Rapid Micro, Apyx Medical, DocGo, Sharps Technology, and Lucid Diagnostics. The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics More
Joint Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Joint Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess The Joint Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.97 | |||
| Information Ratio | 0.1354 | |||
| Maximum Drawdown | 11.0 | |||
| Value At Risk | (2.72) | |||
| Potential Upside | 4.35 |
Joint Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Joint Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Joint Corp's standard deviation. In reality, there are many statistical measures that can use Joint Corp historical prices to predict the future Joint Corp's volatility.| Risk Adjusted Performance | 0.1488 | |||
| Jensen Alpha | 0.2919 | |||
| Total Risk Alpha | 0.1586 | |||
| Sortino Ratio | 0.1486 | |||
| Treynor Ratio | 0.369 |
Joint Corp February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1488 | |||
| Market Risk Adjusted Performance | 0.379 | |||
| Mean Deviation | 1.69 | |||
| Semi Deviation | 1.76 | |||
| Downside Deviation | 1.97 | |||
| Coefficient Of Variation | 565.38 | |||
| Standard Deviation | 2.16 | |||
| Variance | 4.67 | |||
| Information Ratio | 0.1354 | |||
| Jensen Alpha | 0.2919 | |||
| Total Risk Alpha | 0.1586 | |||
| Sortino Ratio | 0.1486 | |||
| Treynor Ratio | 0.369 | |||
| Maximum Drawdown | 11.0 | |||
| Value At Risk | (2.72) | |||
| Potential Upside | 4.35 | |||
| Downside Variance | 3.88 | |||
| Semi Variance | 3.09 | |||
| Expected Short fall | (2.04) | |||
| Skewness | (0.10) | |||
| Kurtosis | 0.4586 |
Joint Corp Backtested Returns
Joint Corp appears to be not too volatile, given 3 months investment horizon. Joint Corp holds Efficiency (Sharpe) Ratio of 0.18, which attests that the entity had a 0.18 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Joint Corp, which you can use to evaluate the volatility of the firm. Please utilize Joint Corp's Risk Adjusted Performance of 0.1488, market risk adjusted performance of 0.379, and Downside Deviation of 1.97 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Joint Corp holds a performance score of 14. The company retains a Market Volatility (i.e., Beta) of 1.01, which attests to a somewhat significant risk relative to the market. Joint Corp returns are very sensitive to returns on the market. As the market goes up or down, Joint Corp is expected to follow. Please check Joint Corp's total risk alpha, as well as the relationship between the downside variance and daily balance of power , to make a quick decision on whether Joint Corp's current trending patterns will revert.
Auto-correlation | 0.56 |
Modest predictability
The Joint Corp has modest predictability. Overlapping area represents the amount of predictability between Joint Corp time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Joint Corp price movement. The serial correlation of 0.56 indicates that roughly 56.0% of current Joint Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.56 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.29 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, The Joint Corp reported net income of (8.53 Million). This is 102.5% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 101.49% higher than that of the company.
Joint Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Joint Corp's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Joint Corp could also be used in its relative valuation, which is a method of valuing Joint Corp by comparing valuation metrics of similar companies.Joint Corp is currently under evaluation in net income category among its peers.
Joint Fundamentals
| Return On Equity | -0.0101 | ||||
| Return On Asset | 1.0E-4 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 122.69 M | ||||
| Shares Outstanding | 14.87 M | ||||
| Shares Owned By Insiders | 14.23 % | ||||
| Shares Owned By Institutions | 78.63 % | ||||
| Number Of Shares Shorted | 953.85 K | ||||
| Price To Earning | 16.57 X | ||||
| Price To Book | 6.57 X | ||||
| Price To Sales | 2.74 X | ||||
| Revenue | 52.16 M | ||||
| Gross Profit | 42.59 M | ||||
| EBITDA | 2.9 M | ||||
| Net Income | (8.53 M) | ||||
| Cash And Equivalents | 9.37 M | ||||
| Cash Per Share | 0.65 X | ||||
| Total Debt | 795.03 K | ||||
| Debt To Equity | 0.82 % | ||||
| Current Ratio | 0.88 X | ||||
| Book Value Per Share | 1.50 X | ||||
| Cash Flow From Operations | 9.42 M | ||||
| Short Ratio | 14.09 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Price To Earnings To Growth | (0.70) X | ||||
| Target Price | 10.67 | ||||
| Number Of Employees | 443 | ||||
| Beta | 1.32 | ||||
| Market Capitalization | 148.24 M | ||||
| Total Asset | 83.15 M | ||||
| Retained Earnings | (27.7 M) | ||||
| Working Capital | 22.84 M | ||||
| Current Asset | 19.03 M | ||||
| Current Liabilities | 7.49 M | ||||
| Net Asset | 83.15 M |
About Joint Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze The Joint Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Joint Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The Joint Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Joint Stock Analysis
When running Joint Corp's price analysis, check to measure Joint Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Joint Corp is operating at the current time. Most of Joint Corp's value examination focuses on studying past and present price action to predict the probability of Joint Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Joint Corp's price. Additionally, you may evaluate how the addition of Joint Corp to your portfolios can decrease your overall portfolio volatility.